Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Christina Baik MD, MPH

Christina Baik MD, MPH

Associate Professor of Medicine, Thoracic, Head and Neck Medical Oncology, Fred Hutchinson Cancer Center, University of Washington School of Medicine, Seattle, Washington

Dr. Christina Baik is an Associate Professor of Medicine at University of Washington and Fred Hutchinson Cancer Center in Seattle, Washington. She is a medical oncologist with clinical expertise is in thoracic malignancies and is actively involved in translational and clinical research in the development of novel targeted therapeutics and understanding of treatment resistance.

Disclosures

Research funding to institution: Daiichi, Abbvie, AstraZeneca, Lilly, Turning Point, Roche, Blueprint, Jansen, Spectrum, Pfizer

Consulting: Blueprint, Daiichi, AstraZeneca, Takeda, TurningPoint, Guardant, Regeneron, Silverback, Pfizer, Jansen

Recent Contributions to PracticeUpdate:

  1. Sintilimab Plus Bevacizumab Biosimilar IBI305 and Chemotherapy for EGFR-Mutated Non-Squamous NSCLC After Progression on EGFR-TKI Therapy

Recently Updated